UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Immunogenic Cell Death and Immunotherapy of Multiple Myeloma

Frontiers in cell and developmental biology, 2019-04, Vol.7, p.50-50

2019

Volltextzugriff (PDF)

Role of Exosomes in the Regulation of T-cell Mediated Immune Responses and in Autoimmune Disease

Cells (Basel, Switzerland), 2019-02, Vol.8 (2), p.154

2019

Volltextzugriff (PDF)

Expanded and activated allogeneic NK cells are cytotoxic against B-chronic lymphocytic leukemia (B-CLL) cells with sporadic cases of resistance

Scientific reports, 2020-11, Vol.10 (1), p.19398-19398, Article 19398

2020

Volltextzugriff (PDF)

Importance of TRAIL Molecular Anatomy in Receptor Oligomerization and Signaling. Implications for Cancer Therapy

Cancers, 2019-03, Vol.11 (4), p.444

2019

Volltextzugriff (PDF)

Expanded NK cells from umbilical cord blood and adult peripheral blood combined with daratumumab are effective against tumor cells from multiple myeloma patients

Oncoimmunology, 2021-01, Vol.10 (1), p.1853314-1853314

2021

Volltextzugriff (PDF)

Bortezomib resistance in a myeloma cell line is associated to PSMβ5 overexpression and polyploidy

Leukemia research, 2012-02, Vol.36 (2), p.212-218

2012

Volltextzugriff (PDF)

Dinaciclib synergizes with BH3 mimetics targeting BCL‐2 and BCL‐XL in multiple myeloma cell lines partially dependent on MCL‐1 and in plasma cells from patients

Molecular oncology, 2023-12, Vol.17 (12), p.2507-2525

2023

Volltextzugriff (PDF)

Study of the Bcl-2 Interactome by BiFC Reveals Differences in the Activation Mechanism of Bax and Bak

Cells (Basel, Switzerland), 2023-03, Vol.12 (5), p.800

2023

Volltextzugriff (PDF)

Ecto-calreticulin expression in multiple myeloma correlates with a failed anti-tumoral immune response and bad prognosis

Oncoimmunology, 2022-12, Vol.11 (1), p.2141973-2141973

2022

Volltextzugriff (PDF)

Harnessing the Potential of NK Cell-Based Immunotherapies against Multiple Myeloma

Cells (Basel, Switzerland), 2022-01, Vol.11 (3), p.392

2022

Volltextzugriff (PDF)

Antimitotic drugs in cancer chemotherapy: Promises and pitfalls

Biochemical pharmacology, 2013-09, Vol.86 (6), p.703-710

2013

Volltextzugriff (PDF)

Response: Commentary: Immunogenic Cell Death and Immunotherapy of Multiple Myeloma

Frontiers in cell and developmental biology, 2019-11, Vol.7, p.306-306

2019

Volltextzugriff (PDF)

Apoptotic Pathways Are Selectively Activated by Granzyme A and/or Granzyme B in CTL-Mediated Target Cell Lysis

The Journal of cell biology, 2004-11, Vol.167 (3), p.457-468

2004

Volltextzugriff (PDF)

Implication of Mitochondrial Hydrogen Peroxide Generation in Ceramide-induced Apoptosis

The Journal of biological chemistry, 1997-08, Vol.272 (34), p.21388-21395

1997

Volltextzugriff (PDF)

Bcl-2 family members as molecular targets in cancer therapy

Biochemical pharmacology, 2008-10, Vol.76 (8), p.939-946

2008

Volltextzugriff (PDF)

Bim is the key mediator of glucocorticoid-induced apoptosis and of its potentiation by rapamycin in human myeloma cells

Biochimica et biophysica acta, 2010-02, Vol.1803 (2), p.311-322

2010

Volltextzugriff (PDF)

Future prospects for mitosis-targeted antitumor therapies

Biochemical pharmacology, 2021-08, Vol.190, p.114655-114655, Article 114655

2021

Volltextzugriff (PDF)

Direct Interaction of Bax and Bak Proteins with Bcl-2 Homology Domain 3 (BH3)-only Proteins in Living Cells Revealed by Fluorescence Complementation

The Journal of biological chemistry, 2013-02, Vol.288 (7), p.4935-4946

2013

Volltextzugriff (PDF)

Audiencias virtuales en los procesos laborales y su vigencia en la postpandemia COVID-19

Ius vocatio (En línea), 2022-06, Vol.5 (5), p.15-30

Salinas Avila, Javier Naval

2022

Volltextzugriff (PDF)

Farnesyltransferase Inhibitor BMS-214662 Induces Apoptosis in Myeloma Cells through PUMA Up-Regulation, Bax and Bak Activation, and Mcl-1 Elimination

Molecular pharmacology, 2005-06, Vol.67 (6), p.1991-1998

2005

Volltextzugriff (PDF)

A Role of the Mitochondrial Apoptosis-Inducing Factor in Granulysin-Induced Apoptosis

The Journal of immunology (1950), 2001-08, Vol.167 (3), p.1222-1229

2001

Volltextzugriff (PDF)

Cell cycle regulation by FasL and Apo2L/TRAIL in human T-cell blasts. Implications for autoimmune lymphoproliferative syndromes

Journal of leukocyte biology, 2008-08, Vol.84 (2), p.488-498

2008

Volltextzugriff (PDF)

Granulysin-Induced Apoptosis. I. Involvement of at Least Two Distinct Pathways

The Journal of immunology (1950), 1998-08, Vol.161 (4), p.1758-1764

1998

Volltextzugriff (PDF)

Inhibition of autophagy with chloroquine potentiates carfilzomib-induced apoptosis in myeloma cells in vitro and in vivo

Cancer letters, 2016-11, Vol.382 (1), p.1-10

2016

Volltextzugriff (PDF)

Targeting the Apo2L/TRAIL system for the therapy of autoimmune diseases and cancer

Biochemical pharmacology, 2012-06, Vol.83 (11), p.1475-1483

2012

Volltextzugriff (PDF)

1 – 25 von 158

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(134)
Mit Volltextzugriff
(139)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Immunogenic Cell Death and Immunotherapy of Multiple Myeloma

Role of Exosomes in the Regulation of T-cell Mediated Immune Responses and in Autoimmune Disease

Expanded and activated allogeneic NK cells are cytotoxic against B-chronic lymphocytic leukemia (B-CLL) cells with sporadic cases of resistance

Importance of TRAIL Molecular Anatomy in Receptor Oligomerization and Signaling. Implications for Cancer Therapy

Expanded NK cells from umbilical cord blood and adult peripheral blood combined with daratumumab are effective against tumor cells from multiple myeloma patients

Bortezomib resistance in a myeloma cell line is associated to PSMβ5 overexpression and polyploidy

Dinaciclib synergizes with BH3 mimetics targeting BCL‐2 and BCL‐XL in multiple myeloma cell lines partially dependent on MCL‐1 and in plasma cells from patients

Study of the Bcl-2 Interactome by BiFC Reveals Differences in the Activation Mechanism of Bax and Bak

Ecto-calreticulin expression in multiple myeloma correlates with a failed anti-tumoral immune response and bad prognosis

Harnessing the Potential of NK Cell-Based Immunotherapies against Multiple Myeloma

Antimitotic drugs in cancer chemotherapy: Promises and pitfalls

Response: Commentary: Immunogenic Cell Death and Immunotherapy of Multiple Myeloma

Apoptotic Pathways Are Selectively Activated by Granzyme A and/or Granzyme B in CTL-Mediated Target Cell Lysis

Implication of Mitochondrial Hydrogen Peroxide Generation in Ceramide-induced Apoptosis

Bcl-2 family members as molecular targets in cancer therapy

Bim is the key mediator of glucocorticoid-induced apoptosis and of its potentiation by rapamycin in human myeloma cells

Future prospects for mitosis-targeted antitumor therapies

Direct Interaction of Bax and Bak Proteins with Bcl-2 Homology Domain 3 (BH3)-only Proteins in Living Cells Revealed by Fluorescence Complementation

Audiencias virtuales en los procesos laborales y su vigencia en la postpandemia COVID-19

Farnesyltransferase Inhibitor BMS-214662 Induces Apoptosis in Myeloma Cells through PUMA Up-Regulation, Bax and Bak Activation, and Mcl-1 Elimination

A Role of the Mitochondrial Apoptosis-Inducing Factor in Granulysin-Induced Apoptosis

Cell cycle regulation by FasL and Apo2L/TRAIL in human T-cell blasts. Implications for autoimmune lymphoproliferative syndromes

Granulysin-Induced Apoptosis. I. Involvement of at Least Two Distinct Pathways

Inhibition of autophagy with chloroquine potentiates carfilzomib-induced apoptosis in myeloma cells in vitro and in vivo

Targeting the Apo2L/TRAIL system for the therapy of autoimmune diseases and cancer

Suchergebnisse filtern